271 related articles for article (PubMed ID: 37511530)
21. Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis.
Ukey S; Jain A; Dwivedi S; Vishnoi JR; Chugh A; Purohit P; Pareek P; Elhence P; Misra S; Sharma P
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S551-S559. PubMed ID: 38384018
[TBL] [Abstract][Full Text] [Related]
22. Qualitative Assessment of Collagen and Elastic Fibers in Oral Submucous Fibrosis (OSMF), OSMF with Dysplasia and Oral Squamous Cell Carcinoma Arising from OSMF: A Histochemical Study.
Pandiar D; Aswani E; Krishnan RP
Head Neck Pathol; 2023 Dec; 17(4):932-939. PubMed ID: 37843734
[TBL] [Abstract][Full Text] [Related]
23. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical biomarkers in oral submucous fibrosis: A scoping review.
Kavitha L; Ranganathan K; Shyam S; Fathima JHS; Umesh W; Warnakulasuriya S
J Oral Pathol Med; 2022 Aug; 51(7):594-602. PubMed ID: 35102645
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
26. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
[TBL] [Abstract][Full Text] [Related]
27. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
Phulari RGS; Dave EJ
Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
[TBL] [Abstract][Full Text] [Related]
28. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
[TBL] [Abstract][Full Text] [Related]
29. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
31. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
33. Quantitative estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous fibrosis--an immunohistochemical study.
Srinivasan M; Jewell SD
Oral Oncol; 2001 Jul; 37(5):461-7. PubMed ID: 11377235
[TBL] [Abstract][Full Text] [Related]
34. Quantitative evaluation of micronuclei in oral squamous cell carcinoma and oral submucous fibrosis patients: a comparative study.
Shah SN; Manjunatha BS; Shah VS; Dagrus K; Soni N; Shah S
Recent Pat Anticancer Drug Discov; 2015; 10(2):233-8. PubMed ID: 25782917
[TBL] [Abstract][Full Text] [Related]
35. HIF - 1α as a marker of risk assessment for malignant transformation in oral submucous fibrosis: An immunohistochemical study.
Sharma K; Shetty DC; Rathore AS; Juneja SA; Katyal S; Krishnatre A
Indian J Pathol Microbiol; 2022; 65(4):761-765. PubMed ID: 36308177
[TBL] [Abstract][Full Text] [Related]
36. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.
Chaturvedi P; Vaishampayan SS; Nair S; Nair D; Agarwal JP; Kane SV; Pawar P; Datta S
Head Neck; 2013 Oct; 35(10):1404-9. PubMed ID: 22972608
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of polo-like kinase 1 in oral squamous cell carcinoma and oral submucous fibrosis.
Vittal K; Pandian SS; Joseph LD; Raj SG
Indian J Dent Res; 2018; 29(2):171-175. PubMed ID: 29652009
[TBL] [Abstract][Full Text] [Related]
38. Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
J Microsc Ultrastruct; 2023; 11(2):75-80. PubMed ID: 37448822
[TBL] [Abstract][Full Text] [Related]
39. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
40. Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: an immunohistochemical study.
Thubashini M; Malathi N; Kannan L
Indian J Dent Res; 2011; 22(2):256-9. PubMed ID: 21891896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
